Awareness, Care & Treatment In Obesity Management

NCT05690789 | Completed

• 2 other identifiers: DAS-009U1111-1267-0332
• Study Type: observational
• Target: 1,688
• Locations: 1 country
• Sites: 1

Brief Summary

ACTION France is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Conditions

Obesity

Outcome Measures

Primary Outcomes (9)

• Weight loss motivators

  Multi-select from defined list

  Day 1-day of survey

• Proportion of PLwO / participants who made serious weight loss effort

  Percentage of participants

  Day 1-day of survey

• Response to weight loss discussions

  Single select from defined list

  Day 1-day of survey

• Effective weight loss methods

  Multi-select from defined list

  Day 1-day of survey

• Obesity attitudes

  5-point Likert scale 1=strongly disagree to 5=strongly agree

  Day 1-day of survey

• Attitudes toward prescription weight loss medication and surgery

  5-point Likert scale 1=strongly disagree to 5=strongly agree

  Day 1-day of survey

• Weight loss barriers

  Multi-select from defined list

  Day 1-day of survey

• Obesity and weight management

  5-point Likert scale 1=strongly disagree to 5=strongly agree

  Day 1-day of survey

• Degree to which healthcare and society is meeting needs of people living with obesity

  5-point Likert scale 1=strongly disagree to 5=strongly agree

  Day 1-day of survey

Secondary Outcomes (7)

• Top factors for improving weight loss outcomes

  Day 1-day of survey

• Types of weight management goals

  Day 1-day of survey

• Most helpful information for participants for weight loss

  Day 1-day of survey

• Responsibility for improving health of people living with obesity

  Day 1-day of survey

• Most helpful support for weight loss

  Day 1-day of survey

Study Arms (3)

People / Person Living with Obesity (PLwO)

From online, general population consumer panels

Other: No treatment given

Health Care Professionals (HCPs)

HCPs treating people who have obesity

Other: No treatment given

Employers

Single-selection response from defined list

Other: No treatment given

Interventions

No treatment given OTHER

No treatment given

Employers; Health Care Professionals (HCPs); People / Person Living with Obesity (PLwO)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatmen, management and employers

You may qualify if:

• People Living with Obesity
• Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• Male or female, aged above or equal to 18 years at the time of signing informed consent Lives in France
• Current BMI based on self-reported height and weight of at least 30 kg/m\^2
• Health Care Professionals
• Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
• Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
• Physician with a license to practice
• Specialty is not surgeon (including bariatric or plastic surgeon)
• Practices in France
• In clinical practice greater than or equal to 2 years
• Spends at least 70 percent time in direct patient care
• Has seen at least 100 patients in past month
• Has seen at least 10 patients in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 kg/m\^2 with or without comorbidities.
• Employers

You may not qualify if:

• People Living with obesity
• Previous participation in this study. Participation is defined as having given online consent in this study
• Currently pregnant
• Participates in intense fitness or body building programs
• Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• Health Care Providers
• Previous participation in this study. Participation is defined as having given informed consent in this study.
• Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
• Employers
• Previous participation in this study. Participation is defined as having given informed consent in this study.
• Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Sponsors & Collaborators

• Novo Nordisk A/S: lead

Study Sites (1)

Novo Nordisk Investigational Site

Puteaux, 92800, France

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Clinical Transparency (dept. 2834)

  Novo Nordisk A/S

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 10, 2023
• First Posted: January 19, 2023
• Study Start: September 27, 2022
• Primary Completion: March 31, 2023
• Study Completion: March 31, 2023
• Last Updated: June 15, 2023

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will share

Locations

FR (1)